Matches in Wikidata for { <http://www.wikidata.org/entity/Q89242983> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q89242983 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q89242983 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89242983 description "scientific article published on 26 October 2014" @default.
- Q89242983 description "wetenschappelijk artikel" @default.
- Q89242983 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q89242983 name "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 name "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 type Item @default.
- Q89242983 label "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 label "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 prefLabel "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 prefLabel "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 P1433 Q89242983-6AD3D871-21A8-4983-9CDC-B42120127C02 @default.
- Q89242983 P1476 Q89242983-75647BD3-8B75-4368-AC9A-0AEDB62767F0 @default.
- Q89242983 P2093 Q89242983-55923B2E-9D9D-41D0-BBE5-C0B5CE1FB45B @default.
- Q89242983 P2093 Q89242983-7351C28B-D554-4DB9-AC2A-D1C3B334F475 @default.
- Q89242983 P2093 Q89242983-9D219BF9-AEAD-47E0-B17A-7F1F687AF668 @default.
- Q89242983 P304 Q89242983-407BF407-5A21-4F1F-AAF0-AAA3A4169330 @default.
- Q89242983 P31 Q89242983-67F34F97-4924-4D34-B1A1-608FE2D14921 @default.
- Q89242983 P356 Q89242983-30A13F17-F2F8-4E2C-A14B-8FD6A71CB509 @default.
- Q89242983 P433 Q89242983-40B48E51-E8A8-4A72-83C2-391F0530F93F @default.
- Q89242983 P478 Q89242983-E33C654A-2CAF-4CB7-8ADA-30E4A475C1F1 @default.
- Q89242983 P577 Q89242983-E35DB930-5911-4123-8510-7E783999252D @default.
- Q89242983 P698 Q89242983-A123CBB9-FE9B-448E-AAF3-F81622FE59AD @default.
- Q89242983 P921 Q89242983-40573D3B-5EEA-44C4-B08A-3318AABE8047 @default.
- Q89242983 P921 Q89242983-553EDC54-AAD8-4655-89DC-396056A8F90D @default.
- Q89242983 P921 Q89242983-A55CDB66-B24F-4C80-85BC-6B6E27B88F68 @default.
- Q89242983 P921 Q89242983-BE088D57-547F-4FEB-A0C3-FC138D368AE0 @default.
- Q89242983 P356 J.JVAL.2014.08.2203 @default.
- Q89242983 P698 27202188 @default.
- Q89242983 P1433 Q15766908 @default.
- Q89242983 P1476 "Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States" @default.
- Q89242983 P2093 "G C Bell" @default.
- Q89242983 P2093 "H L McLeod" @default.
- Q89242983 P2093 "N T Mason" @default.
- Q89242983 P304 "A621-2" @default.
- Q89242983 P31 Q13442814 @default.
- Q89242983 P356 "10.1016/J.JVAL.2014.08.2203" @default.
- Q89242983 P433 "7" @default.
- Q89242983 P478 "17" @default.
- Q89242983 P577 "2014-10-26T00:00:00Z" @default.
- Q89242983 P698 "27202188" @default.
- Q89242983 P921 Q264118 @default.
- Q89242983 P921 Q412236 @default.
- Q89242983 P921 Q55779816 @default.
- Q89242983 P921 Q912147 @default.